Work

PD ‐L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti‐ PD ‐1/ PD ‐ L 1 clinical trials

Year: 2014

Type: article

Study design: Observational Study

Source: Pigment Cell & Melanoma Research

DOI: 10.1111/pcmr.12340

Authors: Jason Madore, Ricardo E. Vilain, Alexander M. Menzies, Hojabr Kakavand, James S. Wilmott, Jessica Hyman, Jennifer H. Yearley, Richard F. Kefford, John F. Thompson, Georgina V. Long, Peter Hersey, Richard A. Scolyer

Institutions: The University of Sydney, Melanoma Institute Australia, Royal Prince Alfred Hospital, Merck & Co., Inc., Rahway, NJ, USA (United States)

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Cancer Institute NSW, Melanoma Institute Australia, National Health and Medical Research Council, National Medical Research Council

OpenAlex ID: W2022465587

FWCI: 17.99

Cites: 23

Cited by: 407

Related to: 10